Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 74.70 INR
Change Today 0.00 / 0.00%
Volume 0.0
CBIO On Other Exchanges
Symbol
Exchange
Natl India
As of 7:06 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

celestial biolabs ltd (CBIO) Snapshot

Open
73.00
Previous Close
69.80
Day High
75.95
Day Low
68.70
52 Week High
04/24/15 - 75.95
52 Week Low
04/25/14 - 17.80
Market Cap
1.2B
Average Volume 10 Days
396.5K
EPS TTM
0.63
Shares Outstanding
16.1M
EX-Date
09/23/09
P/E TM
119.2x
Dividend
--
Dividend Yield
--
Current Stock Chart for CELESTIAL BIOLABS LTD (CBIO)

Related News

No related news articles were found.

celestial biolabs ltd (CBIO) Related Businessweek News

No Related Businessweek News Found

celestial biolabs ltd (CBIO) Details

Celestial Biolabs Limited develops and markets herbal, nutraceutical, and enzyme formulations in India. It offers a range of enzyme products for use in detergent, textile, pulp and paper, poultry feed additives, grain based distillery, molasses based distillery, sugar, and food processing industrial segments. The company’s herbal products include syrups, such as liver tonics, blood purifiers, digestive tonics, and syrup to treat cough and allergic disorders; capsules for joint pains; granules to control stress; oil for pain reliefs and mobility; and creams, as well as various ayurvedic products. It also provides nutraceuticals for GI health, antibacterial/antifungal/antithrombotic/anti-inflammatory, prostate cancer, mental visual function, heart diseases, bone health, cancer, blood sugar, and cardiovascular diseases. The company was formerly known as Celestial Technologies Limited and changed its name to Celestial Technologies Limited in February 2004. Celestial Biolabs Limited was incorporated in 1997 and is based in Hyderabad, India.

Founded in 1997

celestial biolabs ltd (CBIO) Top Compensated Officers

Chairman, Managing Director and Member of Aud...
Total Annual Compensation: 1.2M
Compensation as of Fiscal Year 2014.

celestial biolabs ltd (CBIO) Key Developments

Celestial Biolabs Ltd. Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Celestial Biolabs Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported sales of INR 76.690 million compared to INR 65.849 million a year ago. Profit from operations before other income finance costs and exceptional items was INR 9.569 million compared to INR 7.508 million a year ago. Profit from ordinary activities before tax was INR 4.412 million compared to INR 5.793 million a year ago. Profit from ordinary activities after tax was INR 3.596 million compared to INR 4.721 million a year ago. Net profit for the period was INR 3.596 million compared to INR 4.721 million a year ago. Basic and diluted earnings per share were INR 0.21 compared to INR 0.32 a year ago. For the nine months, the company reported sales of INR 222.761 million compared to INR 152.993 million a year ago. Profit from operations before other income finance costs and exceptional items was INR 25.718 million compared to INR 17.012 million a year ago. Profit from ordinary activities before tax was INR 12.047 million compared to INR 11.867 million a year ago. Profit from ordinary activities after tax was INR 9.819 million compared to INR 9.672 million a year ago. Net profit for the period was INR 9.819 million compared to INR 9.672 million a year ago. Basic and diluted earnings per share were INR 0.57 compared to INR 0.66 a year ago.

Celestial Biolabs Ltd. to Report Q3, 2015 Results on Feb 12, 2015

Celestial Biolabs Ltd. announced that they will report Q3, 2015 results on Feb 12, 2015

Celestial Biolabs Ltd., Board Meeting, Feb 12, 2015

Celestial Biolabs Ltd., Board Meeting, Feb 12, 2015. Agenda: To consider and take on record the un - audited financial results of the company for the third quarter/nine months ended December 31, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CBIO:IN 74.70 INR +4.90

CBIO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CBIO.
View Industry Companies
 

Industry Analysis

CBIO

Industry Average

Valuation CBIO Industry Range
Price/Earnings 100.0x
Price/Sales 4.2x
Price/Book 1.5x
Price/Cash Flow 22.6x
TEV/Sales 4.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELESTIAL BIOLABS LTD, please visit www.celestiallabs.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.